Skip to main content
ARDXArdelyx, Inc.Sell6.3·$6.29
ARDX · Decision

Should you buy Ardelyx (ARDX)?

Updated

Ardelyx offers 28% revenue growth and a forward P/E of 11.0x with roughly 21-to-1 favorable risk/reward and 150% upside to analyst targets, yet business quality sitting just below the minimum floor constrains the position recommendation to avoid until quality metrics recover.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
SELL
Score
6.3/10
Price
$6.29
Entry / Take Profit (TP) / Stop Loss (SL)
/ $14.18 / $5.85

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

Business quality scores at 3.9, sitting just below the 4.0 floor, which constrains position sizing to an avoid recommendation despite strong value and growth characteristics.

Stable
Warnings
Expectation
Quality score recovers above 4.5 for two consecutive quarters, enabling a meaningful position.

CounterThe quality shortfall may be structural: free cash flow margin is 0%, FCF yield is 0.0%, and the FCF quality component scores 3.0 out of 10, suggesting limited near-term recovery in cash-generation quality.

At a forward P/E of 11.0x and PEG of 0.04, the stock trades at an attractive valuation with roughly 21-to-1 in favorable risk/reward and 150% upside to the analyst price target of $14.21.

Stable
Price targets
Expectation
The stock closes above $10.00 within 12 months, capturing a meaningful portion of the upside toward the $14.21 target.

CounterAnalyst coverage is light with a dampened signal, and the options market max pain at $13.00 sits well above the current trading price — a gap that may require a significant catalyst to close.

Revenue is expanding at 28% year-over-year, a pace that, if sustained, would allow the company to grow into its already undemanding valuation without requiring multiple expansion.

Stable
Growth
Expectation
Revenue growth sustains above 10% year-over-year for the next two reported quarters.

CounterThe growth signal carries low confidence, suggesting the underlying revenue trend may be based on limited data; only one confirmed earnings beat and two quarters with unknown results make the growth trajectory difficult to verify independently.

▸ Show 1 more pillar

The stock has dipped below its 200-day moving average, but the average itself is still rising at 2.6% per 30 days and volume accumulation via rising OBV suggests this is a consolidation within an ongoing uptrend rather than a confirmed breakdown.

Stable
Momentum
Expectation
The stock recaptures its 200-day moving average and OBV continues trending higher over the next two quarters.

CounterMomentum at 4.7 remains below the 5.5 strong threshold, RSI and MACD components are both soft, and a 10% short interest in the float could intensify selling pressure if the uptrend interpretation proves incorrect.

→ Full pillar scorecard with all 4 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Business quality scores at 3.9, sitting just below the 4.0 floor, which constrains position sizing to an avoid recommendation despite strong value and growth characteristics.

    Trip ifQuality score rises above 4.5 for 2 consecutive quarters, removing the below-floor constraint.

  • P2At a forward P/E of 11.0x and PEG of 0.04, the stock trades at an attractive valuation with roughly 21-to-1 in favorable risk/reward and 150% upside to the analyst price target of $14.21.

    Trip ifStock price exceeds $12.00, reducing upside to the $14.21 target below 20%.

  • P3Revenue is expanding at 28% year-over-year, a pace that, if sustained, would allow the company to grow into its already undemanding valuation without requiring multiple expansion.

    Trip ifRevenue growth falls below 10% YoY for 2 consecutive quarters.

  • P4The stock has dipped below its 200-day moving average, but the average itself is still rising at 2.6% per 30 days and volume accumulation via rising OBV suggests this is a consolidation within an ongoing uptrend rather than a confirmed breakdown.

    Trip if200-day moving average slope turns negative (below 0%) for 2 consecutive months.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Ardelyx, Inc. (ARDX) is SELL_IF_HOLDING with medium conviction, score 6.3/10 at $6.29. An L1 hard-floor gate blocked the positive-verdict path — Quality below minimum threshold; dimensional pillars cannot lift the engine output above the verdict floor while the L1 gate is active.

2. What would change the verdict

SELL output reflects multiple gate failures; recovery requires a confluence of those gates re-clearing, not a single dimension move.

3. What the engine sees

On the bear side: Quality below floor (3.9 < 4.0). Active engine warnings: Quality below floor (3.9 < 4.0).

4. Entry, target, and stop

The engine's exit framework anchors to a tactical sell band near $6.29, with structural invalidation at $5.85. The asymmetric R:R against a reversal hypothesis is 17.91 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates ARDX — 10-dimension breakdown →

Bear case

  • Quality below floor (3.9 < 4.0)
Home Stocks ARDX Buy or sell?